MicrobiomeTrials
  • Search Trials
  • Conditions
  • Learn
  • About
Data source: ClinicalTrials.gov
This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Sign up for updates
Home/Conditions/Obesity & Metabolic Health
Condition Guide

Obesity & Metabolic Health

Your gut microbiome and your metabolism are deeply linked

Obesity is far more than a calorie equation. The trillions of microbes in the gut influence how energy is extracted from food, how fat is stored, and even how hungry you feel. Microbiome-targeted therapies may transform metabolic health.

View Recruiting Trials

The Microbiome Connection

How Obesity & Metabolic Health relates to gut health

Common Symptoms

  • Excess body weight
  • Insulin resistance
  • High blood sugar
  • Elevated triglycerides
  • Fatty liver disease
  • Chronic low-grade inflammation

How the Microbiome is Involved

Studies comparing obese and lean twins show striking microbiome differences — even when genetics are identical. Gut bacteria regulate appetite hormones like GLP-1 and PYY, affect how much energy is extracted from food, and drive systemic inflammation linked to metabolic syndrome. Transferring microbiomes from lean donors to obese recipients has improved insulin sensitivity in early trials.

Active Trials

View all 1477 trials
A Study of SA030 Injection in Overweight or Obese ParticipantsPhase 1Recruiting
ObeseOverweight
This study is the first time SA030 is being given to people. The goal is to understand how safe it is, how well it is to…
Brisbane, AustraliaEst. completion Apr 24, 2028
View Trial →
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or OverweightPhase 1Recruiting
Chronic Weight Management
This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is de…
San Antonio, United StatesEst. completion Jun 2027
View Trial →
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.Phase 2Recruiting
Type 1 DiabetesOverweight , Obesity
The goal of this 24 week double-blinded, randomized, parallel controlled clinical trial is to learn how semaglutide affe…
Montreal, CanadaEst. completion Sep 1, 2028
View Trial →

Related Conditions

Mental Health & Gut-Brain Axis
The surprising conversation between your gut and your brain
Explore
Irritable Bowel Syndrome (IBS)
Calming the gut-brain storm
Explore
Cancer & the Microbiome
The microbiome as ally in the fight against cancer
Explore

Get notified about new Obesity & Metabolic Health trials

We’ll email you when new recruiting trials for your condition are posted. No spam, ever.